» Authors » Dirk Vordermark

Dirk Vordermark

Explore the profile of Dirk Vordermark including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 243
Citations 2671
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Trommer S, Muller J, Oertel M, Ehret F, Roohani S, Ha H, et al.
Strahlenther Onkol . 2025 Mar; PMID: 40029351
Background: Progression-free (PFS) and overall survival (OS) in UICC stage III non-small cell lung cancer (NSCLC) after definitive concurrent chemoradiotherapy (CRT) can be increased with consolidating immunotherapy. Recent studies have...
2.
3.
Nguyen A, Brosheit S, Vordermark D, Bitter K, Gerlach R, Gernhardt C
Am J Dent . 2025 Feb; 38(1):15-21. PMID: 40000002
Purpose: To evaluate the laboratory microtensile bond strength (µTBS) of universal adhesives applied in etch-and-rinse mode on irradiated and sound human dentin. Methods: Dentin specimens of 135 freshly extracted human...
4.
Stoevesandt D, Steglich J, Bartelt J, Kurch L, McCarten K, Flerlage J, et al.
Radiology . 2025 Jan; 314(1):e232650. PMID: 39835977
Staging of pediatric Hodgkin lymphoma is currently based on the Ann Arbor classification, incorporating the Cotswold modifications and the Lugano classification. The Cotswold modifications provide guidelines for the use of...
5.
Kappler M, Thielemann L, Glass M, Caggegi L, Guttler A, Pyko J, et al.
Int J Mol Sci . 2025 Jan; 25(24. PMID: 39769183
The regulator of the canonical Wnt pathway, leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5), is expressed in the stem cell compartment of several tissues and overexpressed in different human carcinomas....
6.
Werner A, Steckelberg A, Strobel A, Wienke A, Schmidt H, Vordermark D, et al.
BMC Health Serv Res . 2025 Jan; 25(1):13. PMID: 39754236
Background: Cancer requires interdisciplinary intersectoral care. The Care Coordination Instrument (CCI) captures patients' perspectives on cancer care coordination. We aimed to translate, adapt, and validate the CCI for Germany (CCI...
7.
Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, et al.
JAMA Oncol . 2025 Jan; PMID: 39745682
Importance: The current standard-of-care salvage therapy in relapsed/refractory classic Hodgkin lymphoma (cHL) includes consolidation high-dose chemotherapy (HDCT)/autologous stem cell transplant (aSCT). Objective: To investigate whether presalvage risk factors and fludeoxyglucose-18...
8.
Neyazi B, Haghikia A, Mawrin C, Hattingen E, Vordermark D, Sandalcioglu I
Dtsch Arztebl Int . 2024 Dec; 121(25):840-846. PMID: 39628409
Background: Intramedullary tumors are a subgroup of spinal tumors and are associated with high morbidity and mortality. The estimated incidence of spinal tumors in general is 0.74 to 1.6 per...
9.
Guttler A, Darnstaedt E, Knobloch-Sperlich D, Petrenko M, Kessler J, Grosse I, et al.
Antioxidants (Basel) . 2024 Nov; 13(11). PMID: 39594441
The trace element zinc influences a number of biological reactions, including cell growth, apoptosis, and DNA damage, which affect tumor therapy. The natural compound betulinic acid (BA) and its derivatives...
10.
Lang B, Balermpas P, Bauer A, Blum A, Dirschka T, Follmann M, et al.
J Dtsch Dermatol Ges . 2024 Nov; 22(12):1697-1714. PMID: 39584658
Basal cell carcinoma is the most common malignant tumor in the fair-skinned population and its incidence continues to rise. An update of the S2k guideline with the participation of all...